Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

AGM Statement

17 Jun 2021 07:00

RNS Number : 1544C
Anpario PLC
17 June 2021
 

17 June 2021

 

Anpario plc("Anpario" or the "Company")

 

AGM Statement

 

Anpario plc, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, is holding its AGM later today. Peter Lawrence, Chairman, will make the following comments:

 

"The Board would firstly like to thank all our staff and other stakeholders for their continued efforts in ensuring production and delivery of our products to our customers and subsidiaries around the world especially during this challenging period caused by the Covid 19 pandemic.

 

The Company has delivered good sales and improved profit performance with sales at a similar level to last year, which was a very strong comparative period as customers had increased stock levels at the onset of the pandemic. Most regions are performing to plan with China experiencing a very strong performance, benefiting from last year's ban on anti-biotic growth promoters (AGPs) in animal feed. South East Asia's performance is, however, weaker as countries imposed new lockdowns in response to increasing infection rates and, with less tourism which has reduced overall protein consumption.

 

Our Brexit contingency plans are working well, helping to reduce disruption and we now look forward to our efforts coming to fruition now supported by our European stockholding hub.

 

As with most industries, we are experiencing raw material price inflation and some disruption in our supply chains and global shipping operations. However, we are implementing price increases to help mitigate the increase in costs and our export and logistics team is managing to overcome the logistics issues. We expect these challenges to continue until the last quarter of this year.

 

It is worth noting that Anpario's unique formulation technology also benefits customers as we are able to offer solutions which are more cost effective than alternative competitor products.

 

We are encouraged by some recent business development successes including a large Brazilian poultry integrator using Orego-Stim® and growth in Latin America for our aquaculture products, which are currently being launched in specific countries across Asia. Our exciting growth opportunities and strong balance sheet, which is reflected in our strong cash position, gives me confidence that the Company will continue to develop and grow in the years ahead.

 

Finally, this is my last AGM as I retire from the Board today. I would therefore like to take the opportunity to thank all staff and shareholders for their loyalty and support of Anpario in helping to build a successful company which has delivered significant shareholder value. As I hand over the Chair to Kate Allum, I am confident that the board with its newer members, will successfully continue to steer the company through these unusual times to ensure to deliver value to our shareholders.

 

The Company's interims for the six months period ended 30 June 2021 are expected to be announced on 15 September 2021."

 

 

Enquiries:

Anpario plc

Richard Edwards, Chief Executive Officer

+44 (0)7776 417 129

Karen Prior, Group Finance Director

+44 (0)1909 537 380

Peel Hunt LLP (NOMAD and broker)

+44 (0)20 7418 8900

Adrian Trimmings

Andrew Clark

Will Bell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFSERTIRLIL
Date   Source Headline
19th Jul 20072:29 pmRNSBlocklisting Interim Review
16th Jul 20072:00 pmRNSAdditional Listing
12th Jul 200711:30 amRNSTrading Statement
18th Jun 20079:24 amRNSRPM Production Stopped
4th Jun 20074:50 pmRNSDirector/PDMR Shareholding
4th Jun 200711:14 amRNSDirectorate Change
25th May 200710:18 amRNSMine Training Centre
4th May 200712:02 pmRNSDividend Declaration
26th Apr 20077:02 amRNSFinal Results
16th Apr 20073:02 pmRNSDirector/PDMR Shareholding
13th Apr 20073:11 pmRNSDirector/PDMR Shareholding
13th Apr 20073:06 pmRNSRustenburg Directorate
3rd Apr 20072:42 pmRNSDirector/PDMR Shareholding
2nd Apr 200711:17 amRNSDirectorate Change
30th Mar 20073:40 pmRNSAGM Statement
28th Mar 20072:51 pmRNSDirector/PDMR Shareholding
19th Mar 20071:10 pmRNSDividend re-investment
19th Mar 20071:01 pmRNSDirector/PDMR Shareholding
13th Mar 20072:10 pmRNSDividend conversion rate
13th Mar 200711:00 amRNSDirector/PDMR Shareholding
2nd Mar 200712:22 pmRNSDirectorate Change
2nd Mar 20079:34 amRNSRustenburg Platinum
2nd Mar 20079:13 amRNSDirector/PDMR Shareholding
27th Feb 20072:01 pmRNSDirectorate Change
14th Feb 20072:00 pmRNSDirectorate Change
12th Feb 20077:01 amRNSFinal Results
12th Feb 20077:00 amRNSDividend Declaration
18th Jan 20072:40 pmRNSBlocklisting Interim Review
15th Jan 20079:23 amRNSAdditional Listing
12th Jan 20073:30 pmRNSBlocklisting Interim Review
14th Dec 20061:05 pmRNSBEE Transaction
12th Dec 200610:00 amRNSAmandelbult mine
11th Dec 20069:15 amRNSPreference Shares
11th Dec 20069:00 amRNSConversion of pref shares
6th Dec 200611:45 amRNSDirectorate Change
6th Dec 200611:06 amRNSFacility visit
29th Nov 200612:00 pmRNSTrading Statement
27th Nov 200611:56 amRNSResult of EGM
9th Nov 200610:48 amRNSSchedule 1 - Kiotech Int. Plc
9th Nov 20067:00 amRNSFacility visit
8th Nov 20061:02 pmRNSDirector/PDMR Shareholding
8th Nov 200612:00 pmRNSBEE Transaction
7th Nov 20067:01 amRNSDirectorate Change
3rd Nov 20062:00 pmRNSAnooraq-Platinum Proj Update
3rd Nov 20067:30 amRNSRestoration- Kiotech Intl plc
3rd Nov 20067:30 amRNSAcquistion and Placing
27th Oct 20068:52 amRNSDividend Declaration
13th Oct 200611:30 amRNSStatement re. Disposal
13th Oct 200611:30 amRNSPossible Acquisition
13th Oct 200611:30 amRNSSuspension - Kiotech Int

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.